Beruflich Dokumente
Kultur Dokumente
yi
Ma
na
Ya
y
S3 Lec 5: Clostridium by Dr. Maria Cielo B. Malijan, MD, DPPS, FPSDBP
pa
November 5, 2010
Je
is Clostridium Unique to C. perfringens
av
M CHARACTERISTICS A streak of C. perfringens produces a lollipop
vs shape on this medium.
• Gram (-), spore-forming bacilli
GAS GANGRENE
Re
ai • Anaerobes
M • Spores (resistant to heat, disinfection and to air; • Clostridial myonecrosis , Gas Gangrene
n they do not germinate) o Rapidly spreading edema, myositis,
Re • Saprophytic tissue necrosis, gas production and
• Some are commensals in humans and animals toxemia as a complication of wound
co
• Opportunistic pathogens infection
• Causes diseases by toxins produced
Ri
• •
ie
Employ butyric fermentation pathways to Infection maybe:
1. Endogenous clostridia (bowel)
ulf
generate energy causing foul odors
2. exogenous clostridia (soil)
Pa
vs • Includes the ff. species
o Clostridium perfringens
•
Vi
If tissue has been traumatized by foreign body
e Gas gangrene and is devitalized (anaerobic environment)
en Food poisoning clostridial spores in the injured muscle germinate
Arl o Clostridium tetani • Toxin production occurs as bacteria multiply
ňa
Tetanus • Characterized by accumulation of gas and fluid
Ni o Clostridium botulinum and the extensive destruction of muscle and
Botulism
ng
connective tissue.
o Clostridium difficile
da
• PMNs are absent from the site
Pseudomembranous enterocolitis
Da
• Organisms spread to new areas behind
r
destructive action of toxins
Clostridium perfringens
he
ac • Untreated mortality 15%
Page 2 of 5
• Widespread occurrence in nature,
• ability to produce a neurotoxin in food and R of
its spores to inactivation
• Causation : insufficient heating in the process of
food preservation
DIAGNOSIS
• Cultures
• Clinical manifestations
TREATMENT
Page 3 of 5
• Preformed toxin (heat labile)absorbed from • Food containers that bulge may contain gas
intestinal tract, but not inactivated by gastric acid produced by C. botulinum and should not be
or proteolytic enzymes opened or tasted
• Toxin primarily affects cholinergic system, blocks • Prophylactic dose of polyvalent antitoxin by IM to
release of ACH all suspects
• Incubation Period :1-2 days or longer • Immunization for laboratory staff
• Initially :
o Nausea and vomiting BOTULINUM TOXIN (BOTOX)
o Cranial nerves are first affected
o oculomotor muscles affected
o ( diplopia, drooping eyelids with squint)
o descending symmetric paralysis of motor
nerves
o Progressive descending motor loss with
flaccid paralysis,
o no loss of consciousness or sensation
o (+) weakness, sleepiness Bilateral 6th CN palsy Bilateral 6th
o CLINICAL FEATURES CN palsy
Thirsty, difficulty in speech and Without the botulinum toxin With the
swallowing botulinum toxin
Problems of breathing and Clostridium difficile
despair
Abdominal pain and restlessness • Motile, slender, gm(+) rods
Death ( respiratory of cardiac • Large, oval,subterminal spores
failure) • Common in feces of neonates
• commensal in gut of 3-10% of healthy adults
INFANT BOTULISM
TRANSMISSION
• CLINICAL FEATURES :
o Infants 5-20 wks of age • diarrhea
o Ingestion of honey contaminated with • results in contamination of environment with
botulinal spores implicated organisms that form spores
o Susceptibility due to less well established • hospital personnel often responsible for
competing intestinal flora transmission
o Constipation and weak sucking ability and
generalized weakness PSEUDOMEMBRANOUS COLITIS
o can progress to flaccid paralysis and
respiratory arrest • results from elimination of normal intestinal flora
o Called “floppy baby syndrome” through antibiotic treatment
o Mortality rate 1-2 % • Oral antibiotics ( clindamycin, ampicillin,
cephalosporins, tetracyline , Chloramphenicol or
DIAGNOSIS antineoplastic agents) disturb the gut microflora
and make the host susceptible to colonization by
• Organism or toxin is suspected food, vomitus or pathogens and to overgrowth by commensal sp.
feces
• toxin in patient’s blood by toxin-antitoxin VIRULENCE FACTORS
neutralization test in mice
• Toxin A ( enterotoxin)
• Toxin B (cytotoxin)
TREATMENT • Adhesin factor
Page 4 of 5
• depolymerizes actin, destroying the cellular
cytoskeleton
• treated cells form membrane protrusions or blebs Clostridium difficile: large oval subterminal spores
Adhesin factor
PATHOGENESIS
DIAGNOSIS
TREATMENT
• discontinue antibiotics – to restore the normal
flora
• Oral Vancomycin or Metronidazole
• Supportive (fluid and electrolyte losses)
Page 5 of 5